http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2006189338-A
Outgoing Links
Predicate | Object |
---|---|
assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_c1755eede76ea7e719a3e0d2843cd793 |
classificationIPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-53 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-68 |
filingDate | 2005-01-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_fa7df0ec62413cf7c8897f9d774991ab http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d11f8a3a7b4838c02f98105251de1a9e http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_bd888c46b23433311dcf68ef8616807d |
publicationDate | 2006-07-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | JP-2006189338-A |
titleOfInvention | Pre-treatment effect prediction method for inflammatory bowel disease and determination method of treatment effect |
abstract | PROBLEM TO BE SOLVED: To provide a method for predicting a therapeutic effect by a drug for inflammatory bowel disease before treatment, and a method for determining a therapeutic effect by the drug. Before treatment, blood collected from a subject having inflammatory bowel disease is prepared, and the blood is brought into contact with a material that induces production of a physiologically active substance from blood cells. The amount of active substance was measured, and the amount of bioactive substance produced was measured, and it was calculated from the amount of bioactive substance produced before treatment in patients who had a therapeutic effect when a drug was administered to a patient with inflammatory bowel disease. A method of comparing the reference value and predicting the effect before treatment depending on whether it is greater or less than the reference value, and blood collected from a test subject having inflammatory bowel disease before and after the treatment, A method for determining the therapeutic effect of inflammatory bowel disease, in which the amount of the physiologically active substance produced is measured and the amount of the physiologically active substance produced in the blood before and after treatment is compared. . [Selection figure] None |
isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11786224-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2009095340-A http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-101092973-B1 |
priorityDate | 2005-01-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 198.